According to her insurance plan, the medication was fully covered when prescribed for diabetes but explicitly excluded when prescribed for weight loss, despite being the same drug, produced in the same factory, injected in the same way, but billed under a different code for an FDA-Approved condition.
A Crisis Hidden in Plain Sight Policy reformers often discuss healthcare sanity as if it were an abstract good, something that simply happens once spreadsheets align and incentives behave. What … Read more
A Historic Announcement, Numerically Speaking WASHINGTON—Standing before a patriotic arrangement of flags, laminated charts, and a pie graph labeled “Winning,” President Donald Trump announced Monday that prescription drug prices are … Read more
CONFIDENTIAL — INTERNAL DISTRIBUTION ONLYDO NOT FORWARD / DO NOT PRINT / DO NOT ACKNOWLEDGE From: Office of Strategic AlignmentTo: Public Relations, Government Affairs, Messaging, & Narrative IntegrityRe: Sustaining the … Read more
The 340B program thrives by avoiding questions other programs insist on asking, quietly prioritizing institutional flexibility over patient-level proof while regulators celebrate efficiency without the inconvenience of answers.
WASHINGTON—Testifying before Congress on Tuesday, a leading pharmacy benefit manager (PBM) CEO reassured lawmakers that pharmaceutical rebates are, in fact, passed on to patients…